BeiGene (NASDAQ:BGNE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile.

Open	$198.00
Close	$193.64
Volume / Avg.	335.25K / 319.68K
Day Range	$189.60 - $203.00
52 Wk Range	126.97 - 248.16
Market Cap	$20.57B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	2.1%
Days to Cover	3.87

Recent News

Innovent Ditches Low-Value Stake Sale After Investor Outcry

Key Takeaways: Innovent said its intention was to demonstrate executives’ commitment to the overseas business, but the deal was dropped after a backlash over pricing

The Bamboo Works

US Listed Chinese Stocks Dominate Another Week - Li Auto, JD.com Among Top 10 Large Cap Gainers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?

Best performing large-cap stocks in the past week were mostly USA listed Chinese stocks due to additional stimulus measures to boost China's economy.

Lekha Gupta

FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients

The FDA's advisory committee is set to evaluate the use of PD-1 inhibitors in gastric cancer patients, focusing on the risks and benefits for those with varying PD-L1 levels, including low expressers.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$198.00
Close	$193.64
Volume / Avg.	335.25K / 319.68K
Day Range	$189.60 - $203.00
52 Wk Range	126.97 - 248.16
Market Cap	$20.57B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	2.1%
Days to Cover	3.87

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BeiGene (BGNE) stock?

You can purchase shares of BeiGene (NASDAQ:BGNE) through any online brokerage.

View our list of the best stock brokerages

Who are BeiGene (BGNE) competitors?

Other companies in BeiGene’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for BeiGene (BGNE) stock?

BeiGene has a consensus price target of $264.96.

What is the current price for BeiGene (BGNE)?

The stock price for BeiGene (NASDAQ: BGNE) is $193.64 last updated November 12, 2024 at 6:52 PM EST.

Does BeiGene (BGNE) pay a dividend?

There are no upcoming dividends for BeiGene.

When is BeiGene (NASDAQ:BGNE) reporting earnings?

BeiGene’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is BeiGene (BGNE) going to split?

There is no upcoming split for BeiGene.

What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

BeiGene

BeiGene (BGNE) Forecast